Literature DB >> 24468005

Production and expression of RANTES (CCL5) by human disc cells and modulation by IL-1-β and TNF-α in 3D culture.

Helen E Gruber1, Gretchen L Hoelscher2, Jane A Ingram2, Synthia Bethea2, H James Norton3, Edward N Hanley2.   

Abstract

Chemokines act as important secondary inflammatory mediators which are released by cells in response to a variety of stimuli. Chemokines bind to cell surface receptors and act as second-order cytokines with specialized functions in inflammation. The role of RANTES (Regulated upon Activation, Normal T-cell Expressed, and Secreted) (also called CCL5 (chemokine (C-C motif) ligand 5)) has received little attention to date in disc tissue. Microarray analyses of lumbar disc annulus tissue revealed that RANTES expression was significantly upregulated in more degenerated Thompson grades IV and V discs compared to expression levels in grades I, II and III discs (p=0.032). Immunolocalization confirmed the presence of RANTES in the annulus and nucleus of the disc, and localized the RANTES receptors CCR1, CCR3 and CCR5 to cells in the disc. In vitro studies with IL-1-β and TNF-α challenges, both proinflammatory cytokines resulted in elevated levels of RANTES in conditioned media (p<0.01); TNF-α exposure, however, produced significantly greater levels than did IL-1alpha (p<0.0001), suggesting a differential regulation by TNF-α. Local production of RANTES in vivo by annulus and nucleus cells, and in vitro induction of RANTES by proinflammatory cytokines suggest that disc cells are primary effector cells as well as target cells, and thus can mediate physiological immune-related processes during disc degeneration by both autocrine and paracrine signaling.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BioPlex assay; Chemokines; IL-1-β; Immunohistochemistry; Microarray analyses; Proinflammatory cytokines; RANTES; TNF-α

Mesh:

Substances:

Year:  2014        PMID: 24468005     DOI: 10.1016/j.yexmp.2014.01.002

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  7 in total

1.  Senescent intervertebral disc cells exhibit perturbed matrix homeostasis phenotype.

Authors:  Kevin Ngo; Prashanti Patil; Sara J McGowan; Laura J Niedernhofer; Paul D Robbins; James Kang; Gwendolyn Sowa; Nam Vo
Journal:  Mech Ageing Dev       Date:  2017-08-19       Impact factor: 5.432

2.  Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics.

Authors:  Kathryn T Weber; Timothy D Jacobsen; Robert Maidhof; Justin Virojanapa; Chris Overby; Ona Bloom; Shaheda Quraishi; Mitchell Levine; Nadeen O Chahine
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

Review 3.  Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.

Authors:  Z I Johnson; Z R Schoepflin; H Choi; I M Shapiro; M V Risbud
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

4.  Effect of the CCL5-Releasing Fibrin Gel for Intervertebral Disc Regeneration.

Authors:  Zhiyu Zhou; Stephan Zeiter; Tanja Schmid; Daisuke Sakai; James C Iatridis; Guangqian Zhou; R Geoff Richards; Mauro Alini; Sibylle Grad; Zhen Li
Journal:  Cartilage       Date:  2018-03-27       Impact factor: 4.634

5.  Acidification changes affect the inflammasome in human nucleus pulposus cells.

Authors:  Frank J Brand; Mahtab Forouzandeh; Harmanpreet Kaur; Francesco Travascio; Juan Pablo de Rivero Vaccari
Journal:  J Inflamm (Lond)       Date:  2016-08-24       Impact factor: 4.981

6.  Unexpectedly decreased plasma cytokines in patients with chronic back pain.

Authors:  Simona Capossela; David Pavlicek; Alessandro Bertolo; Gunther Landmann; Jivko V Stoyanov
Journal:  J Pain Res       Date:  2018-06-21       Impact factor: 3.133

7.  Differential proteomic analysis of fetal and geriatric lumbar nucleus pulposus: immunoinflammation and age-related intervertebral disc degeneration.

Authors:  Chensheng Qiu; Xiaolin Wu; Jiang Bian; Xuexiao Ma; Guoqing Zhang; Zhu Guo; Yan Wang; Yandong Ci; Qizun Wang; Hongfei Xiang; Bohua Chen
Journal:  BMC Musculoskelet Disord       Date:  2020-06-02       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.